Managing Adverse Effects with Multimodal Cancer Therapy: Pharmacists Perspectives

Managing Adverse Effects with Multimodal Cancer Therapy: Pharmacists Perspectives is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.

Published Date: December 31, 2019
Expiration Date: December 31, 2020

Credits: 2.0 hours (0.20 ceu)

Goal:
The goal of this educational activity is to inform and educate oncology, health-system and specialty pharmacists about emerging combination cancer therapies involving contemporary and conventional therapies, and identification and management of AEs arising from the use of these novel combinations to optimize patient care and outcomes.

Conference Objectives:
Upon completion of this program, participants should be better able to:
• Discuss the rationale for combination therapy in cancer care
• Compare and contrast adverse effects related to the use of targeted therapies, immunotherapy, and cytotoxic chemotherapy
• Describe the impact on adverse effects when targeted therapies are combined with checkpoint inhibitors or cytotoxic chemotherapy
• Formulate effective strategies to monitor for and manage adverse events in patients receiving targeted therapies in combination with chemotherapy or immunotherapy

Additional details will be posted as soon as information is available.